News – RSC Medicinal Chemistry Blog

Archive for the ‘News’ Category

Winner of the 2023 RSC Medicinal Chemistry Emerging Investigator Lectureship

23 May 2023

Congratulations to Dr Christoph Nitsche, recipient of the 2023 RSC Medicinal Chemistry Emerging Investigator Lectureship.

The annual RSC Medicinal Chemistry Emerging Investigator Lectureship recognises a researcher who has made a significant contribution to medicinal chemistry and drug discovery in their independent academic career, and is open to candidates who received their PhD within the last 10 years. The RSC Medicinal Chemistry Editorial Board have selected Dr Nitsche, from the Australian National University, as the winner this year.

“I am honoured to receive the RSC Medicinal Chemistry Emerging Investigator Lectureship, which I owe first and foremost to my students and postdocs for their tireless efforts over the last couple of years. I was fortunate enough to have had great mentors who inspired me to think outside the box and build interdisciplinary bridges. I am most grateful for the generous support I have received from foundations and funding agencies throughout my early career, as they have provided me the freedom to pursue my ideas.” – Dr Christoph Nitsche

Dr Nitsche’s lectureship will be held virtually at date to be confirmed. To stay up to date with future announcements, follow us on Twitter @rsc_medchem and sign-up to our news alerts.

More about Christoph

Dr Nitsche is Associate Professor and ARC Future Fellow at the Australian National University (ANU) in Canberra. He completed his PhD in medicinal chemistry at Heidelberg University, Germany, in 2014 and was awarded a Feodor Lynen Fellowship to undertake postdoctoral work in structural biology at the ANU from 2015 to 2018. After a short period at the Free University of Berlin, he received an ARC Discovery Early Career Research Award in 2019 to return to the ANU as a group leader with the goal to accelerate drug discovery. His most recent honours include the John Wade Early Career Researcher Award, the Peter Schwerdtfeger Award, and the Australian Research Award as top researcher in the field of Medicinal Chemistry. Dr Nitsche’s interdisciplinary research program focuses on infectious diseases, bioorthogonal chemistry, and peptide and protein modification.

Find out more about Christoph and the work his lab is doing on their webpage.

Comments Off on Winner of the 2023 RSC Medicinal Chemistry Emerging Investigator Lectureship

Introducing RSC Medicinal Chemistry Associate Editor, Professor Cynthia Dowd

10 Aug 2022

We are delighted to announce that Professor Cynthia Dowd has joined RSC Medicinal Chemistry as an Associate Editor.

About Cynthia:

Dr. Cynthia Dowd is a Professor of Chemistry at George Washington University (GWU), USA. She obtained a BA in Chemistry from the University of Virginia and a PhD in Medicinal Chemistry from Virginia Commonwealth University (with Dr. Richard Glennon). Following a postdoc at the University of Pennsylvania (with Dr. Irwin Chaiken), Cindy was an intramural scientist at the National Institutes of Health (NIH). There, she led a small molecule chemistry group to discover novel agents against tuberculosis. In 2007, she began her independent career at GWU where her research is focused on the design and synthesis of novel anti-infective therapies directed primarily against tuberculosis, malaria and the ESKAPE pathogens. She is the co-author of many peer-reviewed papers, patents, reviews, and book chapters. She is the recipient of the GWU Bender teaching and DREAM mentorship awards, as well as several large research awards from outside institutions. Find out more about Cindy’s work and research group on her webpage.

Submit your research to Cynthia now!

Cynthia joins our other RSC Medicinal Chemistry Associate Editors, Jian Zhang, Maria Duca and Sally-Ann Poulsen – find out about the full Editorial Board on our webpage.

Check out Cindy’s previous publication in MedChemComm below:

Design of potential bisubstrate inhibitors against Mycobacterium tuberculosis (Mtb) 1-deoxy-d-xylulose 5-phosphate reductoisomerase (Dxr)—evidence of a novel binding mode

Géraldine San Jose, Emily R. Jackson, Eugene Uh, Chinchu Johny, Amanda Haymond, Lindsay Lundberg, Chelsea Pinkham, Kylene Kehn-Hall, Helena I. Boshoff, Robin D. Couch and Cynthia S. Dowd

Med. Chem. Commun., 2013, 4, 1099-1104

Comments Off on Introducing RSC Medicinal Chemistry Associate Editor, Professor Cynthia Dowd

Coming Soon: RSC Medicinal Chemistry themed issue on Covalent Drug Design

07 Jan 2021

We are delighted to announce our newest themed issue on Covalent Drug Design, which is Guest Edited by Dr. Lyn Jones (Dana-Faber Cancer Institute), Prof. Keriann Backus (UCLA), and Prof. Zhengying Pan (Peking University).

This issue on covalent drug design will include areas such as covalent fragment-based drug discovery, reversible covalent warhead design, structure-based drug design and covalent docking and covalent chemical probes, natural products and degraders. For more information about the scope of this issue, or if you would like to contribute an article to this collection, please contact the Editorial Office at medchem-rsc@rsc.org.

Submissions are open from now until 3 June 2021

New research in RSC Medicinal Chemistry is published as Research Articles. This article type encompasses both Communication and Full Paper styles with no strict page limit.

All manuscripts will be subject to the journal’s usual peer review process. Accepted manuscripts will be highlighted together in a dedicated virtual issue alongside an editorial by our guest editors, regardless of submission date, and there will be no delay in the publication of all accepted manuscripts into regular issues of RSC Medicinal Chemistry.

Comments Off on Coming Soon: RSC Medicinal Chemistry themed issue on Covalent Drug Design

Register now for upcoming RSC Medicinal Chemistry Desktop Seminars

15 Sep 2020

We’re excited to announce three upcoming RSC Medicinal Chemistry Desktop Seminars, featuring winners of the 2019 and 2020 RSC Medicinal Chemistry Emerging Investigator Lectureship.

RSC Desktop Seminars are an initiative from the Royal Society of Chemistry to bring cutting-edge research directly to you! Now, more than ever, there is a crucial need for sharing research, and we’re pleased to present alongside Editorial Board members and Associate Editors, two RSC Medicinal Chemistry Emerging Investigator Lectureships in a digital format for the first time ever.

These seminars will cover a wide range of medicinal chemistry topics, from targeting infectious diseases to techniques for candidate identification and the chemistry of drug design. Be sure to register for each seminar individually at the links below!

30th September:

Dr. Chandradhish Ghosh

Professor Sylvie Garneau-Tsodikova

Dr. Chandradhish Ghosh, 2020 RSC Medicinal Chemistry Emerging Investigator Lectureship recipient, (Max Planck Institute of Colloids and Interfaces)
“Fantastic bugs and how to kill them”

Professor Sylvie Garneau-Tsodikova, RSC Medicinal Chemistry Associate Editor, (University of Kentucky)
“Infectious disease research/publishing in time of a pandemic”

Introductions will be given by RSC Medicinal Chemistry Executive Editor, Dr. Katie Lim, and the webinar will be hosted by Dr. Jennifer Lee.

See more information about the speakers and register here!

7th October:

Professor Amanda Hargrove

Professor Jean-Louis Reymond

Professor Amanda Hargrove, 2019 MedChemComm Emerging Investigator Lectureship recipient and ChemComm Advisory Board member, (Duke University)
“Modulating the conformation and function of disease-relevant RNA with small molecules”

Professor Jean-Louis Reymond, RSC Medicinal Chemistry Editorial Board member, (University of Bern)
“GDB and the chemical space: enumeration, visualization, synthesis”

Introductions will be given by RSC Medicinal Chemistry Executive Editor, Dr. Katie Lim, and the webinar will be hosted by Dr. Jennifer Lee.

Registration is open now.

14^th October:

Dr. Yoshinori Ikeura

Professor Sally-Ann Poulsen

Professor Sally-Ann Poulsen, RSC Medicinal Chemistry Associate Editor, (Griffith University)
“The elephant in the room – Fragment screening using mass spectrometry”

Dr. Yoshinori Ikeura, RSC Medicinal Chemistry Editorial Board member, (Axcelead Drug Discovery Partners)
“The chemist’s contribution to the modern era in drug discovery”

Introductions will be given by RSC Medicinal Chemistry Executive Editor, Dr. Katie Lim, and the webinar will be hosted by Dr. Hiromitsu Urakami.

Registration is now open, and you can sign up here!

Comments Off on Register now for upcoming RSC Medicinal Chemistry Desktop Seminars

Outstanding Reviewers for MedChemComm in 2018

14 Mar 2019

We would like to highlight the Outstanding Reviewers for MedChemComm in 2018, as selected by the editorial team, for their significant contribution to the journal. The reviewers have been chosen based on the number, timeliness and quality of the reports completed over the last 12 months.

We would like to say a big thank you to those individuals listed here as well as to all of the reviewers that have supported the journal. Each Outstanding Reviewer will receive a certificate to give recognition for their significant contribution.

Dr Thomas Alanine, Sygnature Discovery (http://orcid.org/0000-0002-3349-0726)
Professor Kelly Chibale, University of Cape Town (http://orcid.org/0000-0003-0731-5286)
Dr Vijay Chudasama, University College London (http://orcid.org/0000-0002-8876-3285)
Dr Brenda Farrell, Baylor College of Medicine (http://orcid.org/0000-0003-0847-6401)
Dr Micha Fridman, Tel Aviv University
Dr Keith Green, University of Kentucky
Dr Jared Hammill, University of Kentucky
Dr Katarzyna Kononowicz, Uniwersytet Jagiellonski w Krakowie Collegium Medicum (http://orcid.org/0000-0002-6752-7443)
Dr Alex Poot, Amsterdam University Medical Center (http://orcid.org/0000-0002-7466-4171)
Dr Brad Sleebs, Walter and Eliza Hall Institute of Medical Research (http://orcid.org/0000-0001-9117-1048)

We would also like to thank the MedChemComm board and the medicinal chemistry community for their continued support of the journal, as authors, reviewers and readers.

If you would like to become a reviewer for our journal, just email us at medchemcomm@rsc.org with details of your research interests and an up-to-date CV or résumé. You can find more details in our author and reviewer resource centre

Comments Off on Outstanding Reviewers for MedChemComm in 2018

Outstanding Reviewers for MedChemComm in 2017

20 Mar 2018

Outstanding Reviewers for MedChemComm in 2017

We would like to highlight the Outstanding Reviewers for MedChemComm in 2017, as selected by the editorial team, for their significant contribution to the journal. The reviewers have been chosen based on the number, timeliness and quality of the reports completed over the last 12 months.

Dr Andreas Brunschweiger, TU Dortmund, Germany, ORCID: 0000-0002-4401-1495
Dr David Colby, University of Mississippi, USA, ORCID: 0000-0002-5434-1690
Professor Paul Furtmüller, BOKU-University of Natural Resources and Life Sciences, Austria, ORCID: 0000-0002-1199-2469
Dr Keith Green, University of Kentucky, USA
Dr Ke Jiang, Stanford University, USA
Dr Mukulesh Mondal, Oakland University, USA
Dr Concepcion Sanchez-Martinez, Lilly, Spain, ORCID: 0000-0003-0221-497X
Professor Mike Waring, Newcastle University, UK, ORCID: 0000-0002-9110-8783
Dr Zhiqiang Yu, Southern Medical University, China
Dr Ye Zhang, Guangxi Normal University, China, ORCID: 0000-0002-6903-5602

We would also like to thank the MedChemComm board and the wider community for their continued support of the journal, as authors, reviewers and readers.

If you would like to become a reviewer for our journal you can find more details in our author and reviewer resource centre

Comments Off on Outstanding Reviewers for MedChemComm in 2017

Outstanding Reviewers for MedChemComm in 2016

24 Feb 2017

Following the success of Peer Review Week in September 2016 (dedicated to reviewer recognition) during which we published a list of our top reviewers, we will continue to recognise the contribution that our reviewers make to the journal by announcing our Outstanding Reviewers each year.

Outstanding Reviewers for MedChemComm in 2016, as selected by the editorial team, have been chosen based on the number, timeliness and quality of the reports completed over the last 12 months.

A big thank you to those individuals listed here as well as to all of the reviewers that have supported the journal. Each Outstanding Reviewer will receive a certificate to give recognition for their significant contribution.

Dr Simone Carradori, University of Chieti-Pescara

Professor David A. Colby, University of Mississippi

Dr Abasaheb Dhawane, Georgia State University

Dr Zhang Jiancun, Chinese Academy of Sciences

Professor Zhengqui Li, Jinan University

Dr Xiaoyun Lu, Chinese Academy of Sciences

Dr Enas Malik, University of Bonn

Dr Sandeep Sundriyal, Imperial College London

Dr Kazuya Tatani, Kissei Pharmaceuticals Co. Ltd.

Dr Xu Yong, Chinese Academy of Sciences

We would also like to thank the MedChemComm boards and the medicinal chemistry community for their continued support of the journal, as authors, reviewers and readers.

If you would like to become a reviewer for our journal, just email us with details of your research interests and an up-to-date CV or résumé. You can find more details in our author and reviewer resource centre

Comments Off on Outstanding Reviewers for MedChemComm in 2016

Top 10 reviewers for MedChemComm

21 Sep 2016

In celebration of Peer Review Week, with the theme around Recognition for Review – we would like to highlight the top 10 reviewers for MedChemComm in 2016, as selected by the editor for their significant contribution to the journal.

Name	Institution
Dr Sandeep Sundriyal	Imperial College London
Dr Abasaheb Dhawane	Georgia State University
Dr Xiaoyun Lu	Guangzhou Institute of Biomedicine and Health
Dr Kazuya Tatani	Kissei Pharmaceutical Co., Ltd.
Dr Zhenqqiu Li	Jinan University
Dr Enas Malik	Rheinische Friedrich Wilhelms Universitat Bonn
Dr Yong Xu	Guangzhou Institute of Biomedicine and Health, CAS
Dr Mingxuan Wu	John Hopkins School of Medicine
Dr Yves Janin	Institut Pasteur
Dr Oleg Tsodikov	University of Kentucky

We would like to say a massive thank you to these reviewers as well as the MedChemComm Editorial and Advisory Boards and all of the Medicinal Chemistry community for their continued support of the journal, as authors, reviewers and readers.

Comments Off on Top 10 reviewers for MedChemComm

Updated guidelines and standards for MedChemComm

14 Jan 2016

We’re about to publish our first new issue of 2016 and with it come some changes to the journal which we hope will enhance MedChemComm for our readers, authors and reviewers.

More detailed scope and significance guidelines
We’ve updated our scope and significance guidelines to provide more detail about the type of research we publish, to help authors decide if MedChemComm is the right journal for their article. Also we now ask authors to provide a very brief statement on submission of their article which describes why their research is a significant advance in their field. This information assists our editors and referees in assessing the article’s suitability for publication in the journal.

Introducing ‘Research Articles’
Primary research articles in MedChemComm, which were previously called ‘Concise Articles’, are now ‘Research Articles’. There’s no change in the length or style of articles; ‘Research Articles’ can accommodate any type of primary research article, including communication and full paper styles. The change in name is purely to better reflect this breadth of style. You’ll start seeing the new article name from issue 2 this year.

Article layout
One of the most important aspects of an article from a reader’s point of view is that it’s easy to find and read, with the key information readily available. Therefore we’ve updated guidelines on writing titles and abstracts, which gives advice on how to make these as impactful as possible. This is something we’ll now ask referees to comment on when assessing a manuscript. Also we’ll be limiting the amount of experimental detail included in the main text to two journal pages. Authors should still provide as much experimental information and data as is required for their research; however anything over the two pages should be included in the supplementary information rather than the main text.

Experimental information and data
It’s important that the research published in MedChemComm has the highest levels of integrity and reproducibility; therefore we’ve updated our guidelines on experimental information and data. These give authors information on how much experimental detail should be included, what data are required and the format in which they should be presented.

Feel free to send us any comments or suggestions about these changes or anything else to do with the journal. Thank you to all our authors, reviewers and readers for your continued support, and I hope you enjoy reading MedChemComm in 2016.

Comments Off on Updated guidelines and standards for MedChemComm

2016 RSC Prizes and Awards in Organic Chemistry & Chemical Biology now open for nomination

23 Oct 2015

The 2016 RSC Prizes and Awards are now open for nomination!

Nominations will close on 15 January 2016.

For more than 140 years, our Prizes and Awards programme has been acknowledging and celebrating exceptional talent in the chemical sciences, and with your support we are hoping that 2016 will even more successful!

Last year’s winners include Chemists such as Prof. Wilfred van der Donk (University of Illinois), Prof. Tim Donohoe (University of Oxford), Prof. Shuli You (Shanghai Institute of Organic Chemistry), Prof. Philip Gale (University of Southampton), Prof. Herman Overkleeft (Leiden University), Prof. Alison Ashcroft and Prof. Sheena Radford (University of Leeds).

This year we have 63 prizes and awards open for nominations of individuals, teams and organisations covering the breadth of the chemical sciences across academia, education and industry.

This year’s prizes in the field of Organic Chemistry & Chemical Biology include:

CBID (Chemistry Biology Interface Division) awards –

Organic Awards –

For 2016 our Longstaff Prize is also open – since 1881 we have awarded this prize once every three years to one of our members who has achieved the most to advance the science of chemistry.

Submit your suggestions now!

Comments Off on 2016 RSC Prizes and Awards in Organic Chemistry & Chemical Biology now open for nomination

RSC Medicinal Chemistry Blog